Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
- PMID: 12799186
- DOI: 10.1016/s0014-4827(03)00138-1
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
Abstract
Bone marrow stromal cells, obtained from postnatal bone marrow, contain progenitors able to differentiate into several mesenchymal lineages. Their use in gene and cell therapy requires their in vitro expansion and calls for the investigation of the culture conditions required to preserve these cells as a stem compartment with high differentiative potential during their life span. Here we report that fibroblast growth factor 2 (FGF-2)-supplemented bone marrow stromal cell primary cultures display an early increase in telomere size followed by a gradual decrease, whereas in control cultures telomere length steadily decreases with increasing population doublings. Together with clonogenic culture conditions, FGF-2 supplementation prolongs the life span of bone marrow stromal cells to more than 70 doublings and maintains their differentiation potential until 50 doublings. These results suggest that FGF-2 in vitro selects for the survival of a particular subset of cells enriched in pluripotent mesenchymal precursors and is useful in obtaining a large number of cells with preserved differentiation potential for mesenchymal tissue repair.
Similar articles
-
Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures.J Cell Physiol. 1995 Nov;165(2):386-97. doi: 10.1002/jcp.1041650220. J Cell Physiol. 1995. PMID: 7593217
-
The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.Exp Hematol. 1998 May;26(5):365-73. Exp Hematol. 1998. PMID: 9590652
-
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.Exp Hematol. 2000 Jun;28(6):707-15. doi: 10.1016/s0301-472x(00)00160-0. Exp Hematol. 2000. PMID: 10880757
-
Basic fibroblast growth factor and hematopoiesis.Leukemia. 1995 Jun;9(6):937-42. Leukemia. 1995. PMID: 7596180 Review.
-
Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells.Leuk Lymphoma. 2005 Mar;46(3):329-33. doi: 10.1080/10428190400019958. Leuk Lymphoma. 2005. PMID: 15621822 Review.
Cited by
-
Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis.PLoS One. 2011;6(7):e22887. doi: 10.1371/journal.pone.0022887. Epub 2011 Jul 27. PLoS One. 2011. PMID: 21818404 Free PMC article.
-
GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.Haematologica. 2014 Nov;99(11):1686-96. doi: 10.3324/haematol.2014.105692. Epub 2014 Aug 22. Haematologica. 2014. PMID: 25150255 Free PMC article.
-
Isolation and characterization of side population stem cells in articular synovial tissue.BMC Musculoskelet Disord. 2008 Jun 12;9:86. doi: 10.1186/1471-2474-9-86. BMC Musculoskelet Disord. 2008. PMID: 18549504 Free PMC article.
-
A Simple High Yield Technique for Isolation of Wharton's Jelly-derived Mesenchymal Stem Cell.Avicenna J Med Biotechnol. 2024 Apr-Jun;16(2):95-103. doi: 10.18502/ajmb.v16i2.14860. Avicenna J Med Biotechnol. 2024. PMID: 38618506 Free PMC article.
-
Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis.PLoS One. 2017 Jan 30;12(1):e0166014. doi: 10.1371/journal.pone.0166014. eCollection 2017. PLoS One. 2017. PMID: 28135282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical